Device and method for the selective delivery of drugs to the myocardium

Claim 2

A process for the selective delivery of drugs or therapeutic agents to the coronary arteries and the heart in a living subject comprising the steps of: determining the time of a left ventricular contraction of the subject, immediately following said left ventrical contraction, inflating a balloon catheter device, which has a distal opening out through which the drug or therapeutic agent can pass, in the subject's ascending aorta immediately above his aortic valve, to obstruct his aorta, after said inflating has started, delivering the drug or therapeutic agent via said balloon catheter device out through said distal opening directly into the subject's coronary arteries continuously and only during diastole by continuously maintaining the drug or therapeutic agent at a pressure greater than the subject's diastolic pressure during diastole and less than the subject's systolic pressure during systole, determining the time of the subject's next left ventricular systole following said left ventricular contraction, and immediately preceding said next left ventricular systole, deflating said balloon catheter device in the subject's aorta.

Claim 3

The process of claim 1 including, before said inflating step, introducing said balloon catheter device into the ascending aorta immediately above the subject's aortic valve.

Claim 4

The process of claim 2 including, said introducing comprising introducing said balloon catheter device into the ascending aorta via a peripheral artery of the subject.

Claim 5

The process of claim 2 including, said introducing comprising introducing said balloon catheter device directly into the subject's ascending aorta via a dacron graft.

Claim 6

The process of claim 1 including, repeating said process as necessary.

Claim 7

The process of claim 1 including, removing said balloon catheter device from the ascending arota via the peripheral artery, after said process is completed.

Claim 8

The process of claim 1 including, said maintaining step including continuously maintaining, during both systole and diastole, the drug or therapeutic agent at a pressure between the subject's diastolic and systolic pressures.

Claim 9

The process of claim 7 including, said pressure consisting of a pressure slightly higher than the subject's diastolic pressure.

Claim 10

The process of claim 1 including, said inflating including temporarily blocking the aortic lumen with the balloon of said balloon catheter device to deliver the drug or therapeutic agent specifically to the myocardium.

Claim 11

A process for the selective delivery of drugs or therapeutic agents to the coronary arteries and the heart in a living subject comprising the steps of: determining the time of a left ventricular contraction of the subject, immediately following said left ventricular contraction, inflating the proximal balloon of a two-balloon catheter device, which has a proximal balloon, a distal balloon, and a distal opening out through which the drug or therapeutic agent can pass, in the subject's ascending aorta immediately above his aortic valve, to obstruct his aorta, after said inflating has started, delivering the drug or therapeutic agent via said balloon catheter device out through said distal opening directly into the subject's coronary arteries continuously and only during diastole by continuously maintaining the drug or therapeutic agent at a pressure greater than the subject's diastolic pressure during diastole and less than the subject's systolic pressure during systole, after said delivering has started, inflating said distal balloon to augment said delivering into the subject's coronary arteries, determining the time of the subject's next left ventricular systole following said left ventricular contraction, and immediately preceding said next left verticular systole, deflating said proximal balloon and said distal balloon in the subject's aorta.

Claim 12

A process for the selective delivery of drugs or therapeutic agents to the coronary arteries and the heart in a living subject comprising the steps of: determining the time of a left ventricular contraction of the subject, immediately following said left ventricular contraction, inflating the proximal balloon of a two-balloon catheter device, which has a proximal balloon, a distal balloon, and a distal opening out through which the drug or therapeutic agent can pass, in the subject's ascending aorta immediately above his aortic valve, to obstruct his aorta, after said inflating has started, delivering the drug or therapeutic agent via said balloon catheter device out through said distal opening directly into the subject's coronary arteries continuously and only during diastole by continuously maintaining the drug or therapeutic agent at a pressure greater than the subject's diastolic pressure during diastole and less than the subject's systolic pressure during systole, after said delivering has started, inflating said distal balloon to augment said delivering into the subject's coronary arteries, determining the time of the subject's next left ventricular systole following said left ventricular contraction, and immediately preceding said next left verticular systole, deflating said proximal balloon and said distal balloon in the subject's aorta.

Claim 13

The process of claim 10 including, before said inflating step, introducing said two-balloon catheter device into the subject's ascending aorta immediately above the subject's aortic valve.

Claim 14

The process of claim 11 including, said introducing comprising introducing said two-balloon catheter device directly into the ascending aorta via a peripheral artery.

Claim 15

The process of claim 11 including, said introducing comprising introducing said two-balloon catheter device directly into the ascending aorta via a dacron graft.

Claim 16

The process of claim 10 including, repeating said process as necessary.

Claim 17

The process of claim 10 including, removing said two-balloon catheter device from the ascending aorta via the subject's peripheral artery, after said process is completed.

Claim 18

The process of claim 10 including, said maintaining step including continuously maintaining, during both systole and diastole, the drug or therapeutic agent at a pressure between the subject's diastolic and systolic pressures.

Claim 19

The process of claim 10 including, said pressure consisting of a pressure slightly higher than the subject's diastolic pressure.

Claim 20

The process of claim 10 including, said inflating including temporarily blocking the subject's aortic lumen with said proximal balloon to allow drug delivery specifically to the myocardium.

Claim 23

The device of claim 19 including, said balloon catheter including at least one internal lumen.

Claim 24

The device of claim 20 including, said balloon catheter including a distal portion connected to said internal lumen and an intra-aortic pumping device to which said internal lumen is proximally connected.

Claim 25

The device of claim 19 including, said balloon catheter including a tip which is open and a proximal port to which said tip is connected for monitoring pressure.

Claim 26

The device of claim 19 including, said balloon catheter comprising a single-balloon catheter.

Claim 27

The device of claim 19 including, said delivering means including an agent delivery system.

Claim 28

The device of claim 24 including, said agent delivery system including liposomes containing the drug.

Claim 29

The device of claim 19 including, said balloon catheter including a balloon which is disc-like in conformation.

Claim 30

The device of claim 19 including, said balloon catheter having a volume of 20 cc to 60 cc.

Claim 31

The device of claim 19 including, said balloon catheter comprising a two-balloon catheter.

Claim 32

The device of claim 28 including, said two-balloon catheter including at least one balloon which is disc-like in conformation.

Claim 33

The device of claim 28 including, said two-balloon catheter including a first proximal balloon and a second distal balloon connected in series with said first proximal balloon.

Claim 34

The device of claim 30 including, said first proximal balloon including a first lumen and said second distal balloon including a second lumen separate from said first lumen and adapted to allow for the separate gas filling of said first proximal balloon and said second distal balloon.

Claim 35

The device of claim 30 including, said inflating means inflating said first proximal balloon, said delivering means including a second balloon inflating means for inflating said second balloon, and said deflating means deflating said first proximal balloon and said second distal balloon.

Claim 36

The device of claim 32 including, said delivering means including a maintaining means for continuously maintaining the pressure on the drug or agent higher than the diastolic pressure but lower than the systolic pressure.

Claim 37

The device of claim 33 including, said injecting means including a giving means for giving the agent through a distal opening of said balloon catheter.

Claim 38

The device of claim 30 including, a timing device attached to said internal lumen.

Claim 39

The device of claim 19 including, said delivering means being adapted to inject thrombolytic agents.

Claim 40

A balloon catheter device for the selective delivery of drugs or therapeutic agents to the coronary arteries and to the heart in a living subject comprising: a gas-inflatable balloon having a disc shape and a valume of 20 cc to 40 cc, such that when it is positioned in the subject's ascending aorta immediately above his aortic valve and inflated, it obstructs his aorta, a gas conveying-catheter connected to said balloon and having an orifice through which gas can pass into said gas-inflatable balloon to inflate said gas-inflatable balloon and out through which gas can pass to deflate said gas-inflatable balloon, and a drug or therapeutic agent delivering catheter passing through said gas-inflatable balloon when inflated and having one end connectable to a drug or therapeutic agent supply and an opposite end having a distal end opening through which the drug or therapeutic agent is delivered into the subject's coronary arteries and heart during diastole.

Claim 41

A balloon catheter device for the selective delivery of drugs or therapeutic agents to the coronary arteries and to the heart in a living subject comprising: a gas-inflatable balloon having a disc shape and a valume of 20 cc to 40 cc, such that when it is positioned in the subject's ascending aorta immediately above his aortic valve and inflated, it obstructs his aorta, a gas conveying-catheter connected to said balloon and having an orifice through which gas can pass into said gas-inflatable balloon to inflate said gas-inflatable balloon and out through which gas can pass to deflate said gas-inflatable balloon, and a drug or therapeutic agent delivering catheter passing through said gas-inflatable balloon when inflated and having one end connectable to a drug or therapeutic agent supply and an opposite end having a distal end opening through which the drug or therapeutic agent is delivered into the subject's coronary arteries and heart during diastole.

Claim 42

The device of claim 37 including, said gas-inflatable balloon defining a proximal balloon, and a gas-inflatable distal balloon positioned between said proximal balloon and said distal end and inflatable, after said proximal balloon has inflated and the drugs or therapeutic agents have commenced being delivered out through said distal end opening, to help drive the drug or therapeutic agent directly into the coronary arteries.

Claim 43

The device of claim 38 including, said gas conveying catheter passing into said distal balloon and having a distal balloon orifice communicating with the interior of said distal balloon and through which gas can pass into or out of said distal balloon to inflate or deflate said distal balloon.

Claim 44

The device of claim 38 including, said orifice of said proximal balloon being larger than said distal balloon orifice such that said distal balloon inflates only after said proximal balloon has inflated.

Claim 45

The device of claim 3 including, a cannulus containing said gas-conveying catheter and said drug or therapeutic agent delivering catheter.

Claim 46

The device of claim 41 including, said cannulus being 3 mm to 5 mm in diameter.

Claim 47

The device of claim 38 including, said proximal balloon including a first lumen and said distal balloon including a second lumen separate from said first lumen and adapted to allow for the separate gas filling of said first proximal balloon and said second distal balloon.

Claim 48

The deviced of claim 37 including, said drug or therapeutic agent delivering catheter including an open distal end tip and a proximal port to which said open distal end tip is connected for monitoring pressure of the drug or therapeutic agent.